{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:22:41Z","timestamp":1781896961980,"version":"3.54.5"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/fbp.0000000000000023","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T09:25:30Z","timestamp":1393579530000},"page":"119-129","source":"Crossref","is-referenced-by-count":40,"title":["Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats"],"prefix":"10.1097","volume":"25","author":[{"given":"Andrew J.","family":"Kwilasz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney S.","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138920111798357357","article-title":"The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.","volume":"12","author":"Alvarez-Jaimes","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"R3-3-20210202","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1476-5381.2012.02208.x","article-title":"The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB(1) and FAAH-independent mechanisms.","volume":"169","author":"Bosier","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/nprot.2007.441","article-title":"Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation.","volume":"2","author":"Carlezon","year":"2007","journal-title":"Nat Protoc"},{"key":"R7-3-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"R8-3-20210202","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1073\/pnas.0401292101","article-title":"Functional disassociation of the central and peripheral fatty acid amide signaling systems.","volume":"101","author":"Cravatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200402000-00001","article-title":"Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.","volume":"15","author":"De Vry","year":"2004","journal-title":"Behav Pharmacol"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2008.12.021","article-title":"The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.","volume":"604","author":"Do Carmo","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.","volume":"313","author":"Fegley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.bjp.0707379","article-title":"The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.","volume":"152","author":"Fowler","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","article-title":"Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.","volume":"67","author":"Guindon","year":"2013","journal-title":"Pharmacol Res"},{"key":"R17-3-20210202","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1139\/Y09-026","article-title":"URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.","volume":"87","author":"Hasanein","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/jpet.103.060079","article-title":"Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.","volume":"308","author":"Hohmann","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","article-title":"An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee.","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"R20-3-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2010.09.006","article-title":"Antagonism of (9)-THC induced behavioral effects by rimonabant: time course studies in rats.","volume":"648","author":"Jarbe","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R21-3-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R22-3-20210202","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1523\/JNEUROSCI.3326-06.2006","article-title":"Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.","volume":"26","author":"Jhaveri","year":"2006","journal-title":"J Neurosci"},{"key":"R23-3-20210202","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2165\/11585260-000000000-00000","article-title":"Role of cannabinoids in the treatment of pain and (painful) spasticity.","volume":"70","author":"Karst","year":"2010","journal-title":"Drugs"},{"key":"R26-3-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.112.197780","article-title":"Dissociable effects of the cannabinoid receptor agonists Delta9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.","volume":"343","author":"Kwilasz","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-3-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M012153","article-title":"An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase.","volume":"52","author":"Long","year":"2011","journal-title":"J Lipid Res"},{"key":"R29-3-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/jpet.112.191478","article-title":"Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.","volume":"342","author":"Miller","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-3-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.108.143487","article-title":"Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.","volume":"329","author":"Naidu","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R32-3-20210202","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.106.106377","article-title":"Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.","volume":"319","author":"Negus","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R33-3-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-60327-323-7_7","article-title":"Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia.","volume":"617","author":"Negus","year":"2010","journal-title":"Methods Mol Biol"},{"key":"R34-3-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-009-1770-6","article-title":"Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.","volume":"210","author":"Negus","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"R35-3-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpain.2011.12.003","article-title":"Effects of the delta opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.","volume":"13","author":"Negus","year":"2012","journal-title":"J pain"},{"key":"R36-3-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/laban.255","article-title":"Expression and treatment of pain-related behavioral depression.","volume":"42","author":"Negus","year":"2013","journal-title":"Lab Anim (NY)"},{"key":"R37-3-20210202","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pain.2009.04.010","article-title":"Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.","volume":"144","author":"Pereira Do Carmo","year":"2009","journal-title":"Pain"},{"key":"R39-3-20210202","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpain.2012.11.006","article-title":"Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.","volume":"14","author":"Rosenberg","year":"2013","journal-title":"J pain"},{"key":"R40-3-20210202","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors.","volume":"140","author":"Ross","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R41-3-20210202","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/bjp.2008.335","article-title":"Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.","volume":"155","author":"Sagar","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R42-3-20210202","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1021\/bi0608008","article-title":"A FAAH-regulated class of N-acyl taurines that activates TRP ion channels.","volume":"45","author":"Saghatelian","year":"2006","journal-title":"Biochemistry"},{"key":"R43-3-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J"},{"key":"R44-3-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.106.117572","article-title":"Antinociceptive pharmacology of N-(4-chlorobenzyl)-N-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor.","volume":"321","author":"Tang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R45-3-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists.","volume":"285","author":"Thomas","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R46-3-20210202","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1021\/tx1002194","article-title":"Inactivation of lipid glyceryl ester metabolism in human THP1 monocytesmacrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.","volume":"23","author":"Xie","year":"2010","journal-title":"Chem Res Toxicol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:26:47Z","timestamp":1746142007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201404000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000023","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}